01—Abstract
Summary
Summary of the 8-K filed April 14, 2025. Cited figures are marked; the original filing is the authoritative source.
On April 14, 2025, S&P Global (SPGI) disclosed via Form 8-K that it, together with its 50/50 joint venture partner CME Group, has signed a definitive agreement to sell OSTTRA, a post-trade solutions provider, to investment funds managed by KKR.
The total enterprise value is $3.1 billiona, subject to customary purchase price adjustments, and proceeds will be split evenly between S&P Global and CME Group. OSTTRA was formed in September 2021 from CME's optimization businesses (Traiana, TriOptima, Reset) and S&P Global's MarkitSERV middleware business, and processes over 80 million trades monthly. For S&P Global, the transaction represents a portfolio optimization move consistent with management's stated strategy of active portfolio management to fund future growth.
The filing discloses only the headline enterprise value; further financial terms, including S&P Global's share of expected gain or proceeds net of taxes, were not provided, so investors should await closing disclosures to assess the earnings and cash flow impact. The deal is expected to close in the second half of 2025, subject to customary conditions and regulatory approvals. Key execution risks include securing regulatory approvals on the expected terms and timing, potential transaction cost overruns, and the accounting and tax treatment of the sale.
The 8-K is furnished under Item 7.01 (Regulation FD), so the press release is not deemed filed for Section 18 liability purposes. Management highlighted that OSTTRA's existing leadership under co-CEOs Guy Rowcliffe and John Stewart will remain in place, and that KKR plans a broad-based employee equity program for the company's nearly 1,500 employees.
02—Key points
Key Highlights
- S&P Global and CME Group agreed to sell OSTTRA, their 50/50 joint venture, to KKR-managed funds at a total enterprise value of $3.1 billion, subject to customary price adjustments.
- Sale proceeds will be divided equally between S&P Global and CME Group under the joint venture's 50/50 ownership structure.
- OSTTRA, formed in September 2021, processes over 80 million trades monthly across interest rates, FX, credit, and equity post-trade workflows.
- The transaction is expected to close in the second half of 2025, subject to customary closing conditions and required regulatory approvals.
- The sale is positioned by management as part of S&P Global's ongoing active portfolio optimization strategy to support future growth.
- Further financial terms, including the specific gain, tax impact, or net proceeds to S&P Global, were not disclosed in the filing.
- KKR plans to create a broad-based equity ownership program for OSTTRA's nearly 1,500 employees after closing, and OSTTRA's current co-CEOs will continue to lead the company.
03—Questions
Frequently Asked Questions
How much is S&P Global receiving from the OSTTRA sale?
The total enterprise value is $3.1 billion, subject to customary purchase price adjustments, and it will be split evenly with CME Group under their 50/50 joint venture. This implies roughly $1.55 billion before adjustments, taxes, and transaction costs for S&P Global, though the filing does not state the net amount or the accounting gain.
When is the OSTTRA transaction expected to close?
The transaction is expected to close in the second half of 2025, subject to customary closing conditions and receipt of required regulatory approvals.
What is OSTTRA and why is it being sold?
OSTTRA is a post-trade solutions provider for the global OTC market, formed in 2021 from CME Group's optimization businesses and S&P Global's MarkitSERV middleware business. The sale is described by management as active portfolio optimization supporting S&P Global's strategy and future growth.
What risks could prevent or delay the deal?
Key risks include failing to obtain regulatory approvals on the expected terms or in a timely manner, the transaction proving more expensive than anticipated, and uncertainty around the accounting and tax treatment. The forward-looking statements also cite broader economic and market conditions as factors.
What happens to OSTTRA's employees and management?
OSTTRA's management team, led by co-CEOs Guy Rowcliffe and John Stewart, will continue in their current roles. After closing, KKR plans to support a broad-based equity ownership program for the company's nearly 1,500 employees.
04—Continue